The goal of the proposed cell model study is twofold: (a) to test whether the microenvironment of RA alters DEC1 expression and what the pathological significance is and (b) to make direct signaling connection of DEC1 with the PI3K/β-catenin/NFATc1 pathway. This evidence concerns the gene BHLHE40 and rheumatoid arthritis.